ClinicalTrials.govpublic full text
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
metastatic hormone-receptor-positive (hr+) breast cancer, her2-negative breast cancer, metastatic epithelial ovarian cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 307438
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.